Hormone Replacement Therapy (HRT) Market Size, Share & Trends
Analysis Report and Segment Forecast, 2022| Grand View Research, Inc
“The global hormone replacement therapy market size was valued at USD 15.1
billion in 2014 and is expected to grow at a CAGR of 8.2% in coming years.”
Global Hormone Replacement Therapy Market is expected to reach USD 28.4 billion by 2022, according to a
new report by Grand View Research, Inc. Increasing geriatric and neonatal population base, growing cases of
hormonal imbalances, and large presence of unmet healthcare needs in emerging economies are s ome vital
impact rendering drivers.
Estrogen replacement therapy dominated the market in 2015. Moreover, the rising number of women reaching
the menopausal age is expected to drive the demand for these treatments over the forecast period.
Furthermore, rise in premature births that lead to genital disorders and slower rate of growth in these neonates
are anticipated to fuel the demand for growth hormone therapy. According to statistics provided by the CDC,
over 15 million babies were born preterm in 2014 annually. This number is anticipated to rise over the next
seven years and become a leading cause for disabilities, illnesses, arrested development, and mortality.
To request a sample copy or view summary of this report, click the link below:
http://www.grandviewresearch.com/industry-analysis/hormone-replacement-therapy-market
Further key findings from the study suggest:

Estrogen therapy is expected to dominate the product segment and hold over 50.0% of the market
share by 2022. This growth can be attributed to the increasing focus of healthcare bodies such as the
Women’s Health Initiative, The North America Menopause Society, and The British Menopause Society,
on providing safe replacement therapy.
Follow Us:

The parenteral route of administration is commonly used for delivery of drugs such as Nutropin,
Signifor, Genotropin, and Tev-Tropin. Other routes such as pen-based delivery systems and implants are
gaining popularity owing to higher patient comfort and ease-of-use. Furthermore, technological
advancements in the field providing higher bioavailability of drug and needle-free administration are
predicted to positively impact growth.

Menopause and their vasomotor symptoms are expected to be the most prevalent disease over the
forecast period owing to increasing number of women approaching the menopausal age. The segment is
predicted to hold about 40.0% of the market share by 2022.

North America, particularly the U.S. dominated the market and held about 35.0% of the total revenue in
2015. Existence of well-regulated healthcare system and presence of a large pool of target population
are a few factors that promote growth. Countries such as South Africa, China, India, and Brazil are
anticipated to witness lucrative growth over the forecast period, with China predicted to have the
fastest growth of over 10.0%.

Some key companies catering to hormone replacement therapies include Pfizer, Inc., Merck Serono,
Novo Nordisk, Eli Lilly, Bayer Healthcare, Mylan Laboratories, Amgen, Novartis, and Genentech.
Introduction of new formulations and development of innovative drug delivery systems are expected to
be a few initiatives taken by these players over the forecast period.
Grand View Research has segmented the hormone replacement therapy market on the basis of product, route
of administration, disease type, and region
Hormone Replacement Therapy Market Product Outlook (Revenue, USD Million, 2012 - 2022)

Estrogen Replacement Therapy

Human Growth Hormone Replacement Therapy

Thyroid Replacement Therapy

Other
Hormone Replacement Therapy Market Route Of Administration Outlook (Revenue, USD Million, 2012 2022)

Oral

Parenteral

Transdermal

Other
Hormone Replacement Therapy Market Type Of Disease Outlook (Revenue, USD Million, 2012 - 2022)
Follow Us:

Menopause

Hypothyroidism

Male Hypogonadism

Growth Hormone Deficiency

Other
Hormone Replacement Therapy Market Regional Outlook (Revenue, USD Million, 2012 - 2022)





North America
o
U.S.
o
Canada
Europe
o
UK
o
Germany
Asia Pacific
o
Japan
o
China
Latin America
o
Brazil
o
Mexico
MEA
Follow Us:
o
South Africa
o
Saudi Arabia
Table of Content of Hormone Replacement Therapy (HRT) Market
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
1.3. List of Data Sources
Chapter 2. Executive Summary
2.1. Hormone Replacement Therapy Market - Industry Snapshot and Key Buying Criteria, 2014
Chapter 3. Global Hormone Replacement Therapy Market Industry Outlook
3.1. Hormone Replacement Therapy Market: Segmentation
3.2. Hormone Replacement Therapy Market: Size And Growth Prospects
3.3. Hormone Replacement Therapy Market: Market Dynamics
3.3.1. Market Driver Analysis
3.3.2. Market Restraint Analysis
3.4. Key Opportunities Prioritized
3.5. Industry Analysis - Porter's
3.6. Hormone replacement therapy Market: PESTEL Analysis, 2015
Chapter 4. Global Hormone Replacement Therapy Market Product Outlook
4.1. Hormone Replacement Therapy Market Share,By Product, 2015& 2022
4.2. Estrogen Replacement Therapy
4.2.1. Estrogen Replacement Therapy Market Estimates And Forecasts, 2012 - 2022 (USD Million)
4.3. Human Growth Hormone (HGH) Replacement Therapy
4.3.1. HGH Replacement Therapy Market Estimates And Forecasts, 2012 - 2022 (USD Million)
4.4. Thyroid Replacement Therapy
4.4.1. Thyroid Replacement Therapy Market Estimates And Forecasts, 2012 - 2022 (USD Million)
4.5. Other Replacement Therapy
4.5.1. Other Replacement Therapy Market Estimates And Forecasts, 2012 - 2022 (USD Million)
Chapter 5. Global Hormone Replacement Therapy Market Route Of AdministrationOutlook
5.1. Hormone Replacement Therapy Market Share, By Route Of Administration, 2015& 2022
5.2. Oral Route Based Hormone Replacement Therapy
5.2.1. OralRoute Based Hormone Replacement Therapy Market Estimates And Forecasts, 2012 - 2022
(USD Million)
5.3. Parenteral Route Based Hormone Replacement Therapy
5.3.1. Parenteral Route Based Hormone Replacement Therapy Market Estimates And Forecasts, 2012 2022 (USD Million)
5.4. Transdermal Route Based Hormone Replacement Therapy
5.4.1. Transdermal Route Based Hormone Replacement Therapy Market Estimates And Forecasts,
2012 - 2022 (USD Million)
5.5. Other Route Based Hormone Replacement Therapy
5.5.1. Other Route Based Hormone Replacement Therapy Market Estimates And Forecasts, 2012 -
Follow Us:
2022 (USD Million)
Chapter 6. Global Hormone Replacement Therapy Market Type Of DiseaseOutlook
6.1. Hormone Replacement Therapy Market Share, By Type Of Disease, 2015& 2022
6.2. Menopause
6.2.1. Menopause Based Hormone Replacement Therapy Market Estimates And Forecasts, 2012 2022 (USD Million)
6.3. Hypothyroidism
6.3.1. Hypothyroidism Based Hormone Replacement Therapy Market Estimates And Forecasts, 2012 2022 (USD Million)
6.4. Male Hypogonadism
6.4.1. Male Hypogonadism Based Hormone Replacement Therapy Market Estimates And Forecasts,
2012 - 2022 (USD Million)
6.5. Growth Hormone Deficiency
6.5.1. Growth Hormone Deficiency Based Hormone Replacement Therapy Market Estimates And
Forecasts, 2012 - 2022 (USD Million)
6.6. Other
6.6.1. Other Disease Based Hormone Replacement Therapy Market Estimates And Forecasts, 2012 2022 (USD Million)
6.6.2. Others Market Estimates And Forecasts, 2012 - 2022 (USD Million)
Chapter 7. Global Hormone Replacement Therapy Market Regional Outlook
7.1. Hormone Replacement Therapy Market Share, By Region, 2015& 2022
7.2. North America
7.2.1. North America Hormone Replacement Therapy Market Estimates And Forecasts, By Product,
2012 - 2022 (USD Million)
7.2.2. North America Hormone Replacement Therapy Market Estimates And Forecasts, By Route Of
Administration, 2012 - 2022 (USD Million)
7.2.3. North America Hormone Replacement Therapy Market Estimates And Forecasts, By Type Of
Disease, 2012 - 2022 (USD Million)
7.2.3.1. U.S. Estimates and Forecasts
7.2.3.2. Canada Estimates and Forecasts
7.3. Europe
7.3.1. Europe Hormone Replacement Therapy Market Estimates And Forecasts, By Product, 2012 2022 (USD Million)
7.3.2. Europe Hormone Replacement Therapy Market Estimates And Forecasts, By Route Of
Administration, 2012 - 2022 (USD Million)
7.3.3. Europe Hormone Replacement Therapy Market Estimates And Forecasts, By Type Of Disease,
2012 - 2022 (USD Million)
7.3.3.1. UK Estimates and Forecasts
7.3.3.2. Germany Estimates and Forecasts
7.4. Asia Pacific
Follow Us:
7.4.1. Asia Pacific Hormone Replacement Therapy Market Estimates And Forecasts, By Product, 2012 2022 (USD Million)
7.4.2. Asia Pacific Hormone Replacement Therapy Market Estimates And Forecasts, By Route Of
Administration, 2012 - 2022 (USD Million)
7.4.3. Asia Pacific Hormone Replacement Therapy Market Estimates And Forecasts, By Type Of
Disease, 2012 - 2022 (USD Million)
7.4.3.1. Japan Estimates and Forecasts
7.4.3.2. China Estimates and Forecasts
7.5. Latin America
7.5.1. Latin America Hormone Replacement Therapy Market Estimates And Forecasts, By Product,
2012 - 2022 (USD Million)
7.5.2. Latin America Hormone Replacement Therapy Market Estimates And Forecasts, By Route Of
Administration, 2012 - 2022 (USD Million)
7.5.3. Latin America Hormone Replacement Therapy Market Estimates And Forecasts, By Type Of
Disease, 2012 - 2022 (USD Million)
7.5.3.1. Brazil Estimates and Forecasts
7.5.3.2. Mexico Estimates and Forecasts
7.6. MEA
7.6.1. MEA Hormone Replacement Therapy Market Estimates And Forecasts, By Product, 2012 - 2022
(USD Million)
7.6.2. MEA Hormone Replacement Therapy Market Estimates And Forecasts, By Route Of
Administration, 2012 - 2022 (USD Million)
7.6.3. MEA Hormone Replacement Therapy Market Estimates And Forecasts, By Type Of Disease, 2012
- 2022 (USD Million)
7.6.3.1. South Africa Estimates and Forecasts
7.6.3.2. Saudi Arabia Estimates and Forecasts
Chapter 8. Competitive Landscape
8.1. Abbott Laboratories
8.1.1. Company Overview
8.1.2. Financial Performance
8.1.3. Product Benchmarking
8.1.4. Strategic Initiatives
8.2. Novartis
8.2.1. Company Overview
8.2.2. Financial Performance
8.2.3. Product Benchmarking
8.2.4. Strategic Initiatives
8.3. Pfizer
8.3.1. Company Overview
8.3.2. Financial Performance
Follow Us:
8.3.3. Product Benchmarking
8.3.4. Strategic Initiatives
8.4. Mylan Laboratories
8.4.1. Company Overview
8.4.2. Financial Performance
8.4.3. Product Benchmarking
8.4.4. Strategic Initiatives
8.5. Merck & Co.
8.5.1. Company Overview
8.5.2. Financial Performance
8.5.3. Product Benchmarking
8.5.4. Strategic Initiatives
8.6. Amgen
8.6.1. Company Overview
8.6.2. Financial Performance
8.6.3. Product Benchmarking
8.6.4. Strategic Initiatives
8.7. Novo Nordisk
8.7.1. Company Overview
8.7.2. Financial Performance
8.7.3. Product Benchmarking
8.7.4. Strategic Initiatives
8.8. Bayer
8.8.1. Company Overview
8.8.2. Financial Performance
8.8.3. Product Benchmarking
8.8.4. Strategic Initiatives
8.9. Eli Lily
8.9.1. Company Overview
8.9.2. Financial Performance
8.9.3. Product Benchmarking
8.9.4. Strategic Initiatives
8.10. Wyeth
8.10.1. Company Overview
8.10.2. Financial Performance
8.10.3. Product Benchmarking
8.10.4. Strategic Initiatives
8.11. Genentech
8.11.1. Company Overview
8.11.2. Financial Performance
Follow Us:
8.11.3. Product Benchmarking
8.11.4. Strategic Initiatives
About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated research reports, customized
research reports, and consulting services. To help clients make informed business decisions, the company offers
market intelligence studies ensuring relevant and fact-based research across a range of industries including
technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: [email protected]
For More Information: https://www.grandviewresearch.com
Blog: https://healthcareforecastreport.blogspot.com/
Follow Us:

Global hormone replacement therapy market is expected to reach USD 28.4 billion by 2022